Clomipramine hydrochloride 是5-羟色胺转运体(SERT)、去甲肾上腺素转运体(NET)和多巴胺转运体(DAT)阻断剂,Ki分别为0.14,54和3 nM。
Clomipramine HCl is a hydrochloride salt of clomipramine which is a serotonin transporter (SERT), norepinephrine transporter (NET) dopamine transporter (DAT) blocker with Ki of 0.14, 54 and 3 nM, respectively.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Owens, M.J., et al. 1997. J. Pharmacol. Exp. Ther. 283: 1305-1322. PMID: 9400006
[2] Ortiz, J. and Artigas, F. 1992. Br. J. Pharmacol. 105: 941-946. PMID: 1387022
[3] McTavish, D. and Benfield, P. 1990. Drugs. 39: 136-153. PMID: 2178909
分子式 C19H24Cl2N2 |
分子量 351.31 |
CAS号 17321-77-6 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 70 mg/mL |
Water 70 mg/mL |
Ethanol 70 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT02028598 | Healthy | Drug: Treatment 1|Drug: Treatment 2|Drug: Treatment 3 | CTC Bio, Inc.|Symyoo | Phase 1 | 2014-01-01 | 2014-09-12 |
NCT00564564 | Obsessive Compulsive Disorder | Drug: Quetiapine|Drug: Clomipramine | University of Sao Paulo|Conselho Nacional de Desenvolvimento Cientfico e Tecnolgico | Phase 4 | 2006-01-01 | 2008-02-04 |
NCT02571101 | Premature Ejaculation | Drug: CDFR0812-15/25mg|Drug: CDFR0812-15/50mg|Drug: Condencia|Drug: CDFR0812-Placebo|Drug: Condencia-Placebo | CTC Bio, Inc.|Symyoo | Phase 2 | 2015-11-01 | 2015-12-16 |
NCT00913783 | Depression | Drug: Clomipramine Hydrochloride 25 mg Capsules (Geneva Pharmaceuticals)|Drug: Anafranil Clomipramine Hydrochloride 25 mg Capsules (Basel) | Sandoz | Phase 1 | 1992-11-01 | 2017-03-27 |
NCT00913952 | Depression | Drug: Geneva 25 mg Clomipramine Hydrochloride Capsules Under Fasting Conditions|Drug: Geneva 25 mg Clomipramine Hydrochloride Capsules Under Fed Conditions|Drug: Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fed Conditions | Sandoz | Phase 1 | 1994-04-01 | 2017-03-27 |
NCT00004310 | Obsessive-Compulsive Disorder | Drug: Clomipramine | National Center for Research Resources (NCRR)|Stanford University | Phase 2 | 1999-10-01 | 2005-06-23 |
NCT00466609 | Obsessive Compulsive Disorder | Drug: clomipramine and fluoxetine|Drug: quetiapine and fluoxetine|Drug: placebo and fluoxetine | University of Sao Paulo|Fundao de Amparo Pesquisa do Estado de So Paulo|Conselho Nacional de Desenvolvimento Cientfico e Tecnolgico|Novartis | Phase 4 | 2007-05-01 | 2010-05-12 |
NCT01575158 | Depression | Drug: Citalopram|Drug: Clomipramine|Drug: placebo | University of Aarhus|Danish University Antidepressant Group | 1997-10-01 | 2012-04-10 | |
NCT01439984 | Premature Ejaculation | Drug: Clomipramine | Symyoo | Phase 3 | 2011-09-01 | 2012-10-01 |
NCT01404871 | Obsessive Compulsive Disorder | Drug: clomipramine|Drug: escitalopram|Drug: duloxetine | Sunnybrook Health Sciences Centre|Obsessive Compulsive Foundation|Centre for Addiction and Mental Health | 2009-04-01 | 2013-01-30 | |
NCT00254735 | Obsessive Compulsive Disorder | Drug: quetiapine fumarate|Drug: SSRI/Clomipramine | AstraZeneca | Phase 3 | 2002-04-01 | 2007-12-14 |
NCT01203202 | Premature Ejaculation | Drug: Clomipramine | Symyoo | Phase 2 | 2010-09-01 | 2012-10-01 |
NCT00964886 | Back Pain | Behavioral: cognitive behavioral therapy|Drug: desipramine hydrochloride|Behavioral: cognitive behavioral therapy|Drug: benztropine mesylate 0.125 mg daily|Drug: desipramine hydrochloride | VA Office of Research and Development|University of California, San Diego | Phase 2 | 2010-01-01 | 2016-11-23 |
NCT01896349 | Treatment Resistant Depression | Other: IPT+ antidepressant drugs|Drug: fluoxetine|Drug: sertraline|Drug: paroxetine|Drug: Citalopram|Drug: escitalopram|Drug: fluvoxamine|Drug: Venlafaxine|Drug: Duloxetine|Drug: Bupropion|Drug: Lithium|Drug: Risperidone|Drug: tranylcypromine|Drug: Imipramine|Drug: amitriptyline|Drug: Clomipramine|Drug: nortriptyline|Drug: trazodone|Drug: Mirtazapine|Drug: sulpiride | Hospital de Clinicas de Porto Alegre | 2013-04-01 | 2013-07-10 | |
NCT00018200 | Back Pain|Sciatica | Drug: Desipramine|Drug: Fluoxetine|Drug: Benztropine | VA Office of Research and Development | Phase 2 | 1999-04-01 | 2012-06-04 |
NCT00944996 | Major Depression | Drug: SSRI; SNRI; TCA | Tirat Carmel Mental Health Center|University of Michigan|Ariel University|The Nazareth Hospital, Israel | 2009-06-01 | 2012-07-25 | |
NCT01148316 | Obsessive-Compulsive Disorder | Drug: fluoxetine|Behavioral: Group cognitive-behavioral therapy | Roseli Shavitt|University of Pernambuco|University of Sao Paulo | 2010-08-01 | 2014-10-23 | |
NCT02431845 | Obsessive-Compulsive Disorder | Drug: SSRIs | Severance Hospital | 2013-01-01 | 2015-11-16 | |
NCT00704860 | Major Depression | Other: Open label pharmacotherapy | University of Ottawa | Phase 4 | 2005-02-01 | 2011-01-18 |
NCT01944657 | 1. Major Depressive Disorder. | Device: Supplemental TMS|Drug: Standard Medication Monotherapy | Sheppard Pratt Health System|Central Michigan University | 2013-09-01 | 2014-11-03 | |
NCT00074815 | Obsessive-Compulsive Disorder | Drug: Serotonin reuptake inhibitors management|Behavioral: Cognitive behavioral therapy by a psychologist|Behavioral: Instructional cognitive behavioral therapy by a psychiatrist | Duke University|National Institute of Mental Health (NIMH) | Phase 3 | 2003-09-01 | 2014-07-23 |
NCT02374567 | Dementia|Depression|Schizophrenia|Psychosomatic Disorders|Anxiety Disorders | Drug: Phenobarbital|Drug: Phenytoin|Drug: Carbamazepine|Drug: Oxcarbazepine|Drug: Valproic Acid|Drug: Lamotrigine|Drug: Topiramate|Drug: Gabapentin|Drug: Levetiracetam|Drug: Pregabalin|Drug: Lacosamide|Drug: Clonazepam|Drug: Biperiden|Drug: Levomepromazine|Drug: Fluphenazine|Drug: Perphenazine|Drug: Perazine|Drug: Thioridazine|Drug: Haloperidol|Drug: Melperone|Drug: Pipamperone|Drug: Bromperidol|Drug: Benperidol|Drug: Sertindole|Drug: Ziprasidone|Drug: Flupentixol|Drug: Chlorprothixene|Drug: Zuclopenthixol|Drug: Fluspirilene|Drug: Pimozide|Drug: Clozapine|Drug: Olanzapine|Drug: Quetiapine|Drug: Sulpiride|Drug: Tiapride|Drug: Amisulpride|Drug: Prothipendyl|Drug: Risperidone|Drug: Aripiprazole|Drug: Paliperidone|Drug: Diazepam|Drug: Oxazepam|Drug: Lorazepam|Drug: Bromazepam|Drug: Clobazam|Drug: Alprazolam|Drug: Hydroxyzine|Drug: Buspirone|Drug: Chloral Hydrate|Drug: Flurazepam|Drug: Nitrazepam|Drug: Triazolam|Drug: Lormetazepam|Drug: Temazepam|Drug: Midazolam|Drug: Brotizolam|Drug: Zopiclone|Drug: Zolpidem|Drug: Zaleplon|Drug: Melatonin|Drug: Clomethiazole|Drug: Diphenhydramine|Drug: Promethazine|Drug: Imipramine|Drug: Clomipramine|Drug: Opipramol|Drug: Trimipramine|Drug: Amitriptyline|Drug: Nortriptyline|Drug: Doxepin|Drug: Maprotiline|Drug: Amitriptyline oxide|Drug: Fluoxetine|Drug: Citalopram|Drug: Paroxetine|Drug: Sertraline|Drug: Fluvoxamine|Drug: Escitalopram|Drug: Tranylcypromine|Drug: Moclobemide|Drug: Mianserin|Drug: Trazodone|Drug: Mirtazapine|Drug: Bupropion|Drug: Venlafaxine|Drug: Reboxetine|Drug: Duloxetine|Drug: Agomelatine|Drug: Pyritinol|Drug: Piracetam|Drug: Donepezil|Drug: Rivastigmine|Drug: Galantamine|Drug: Memantine|Drug: Nicergoline|Drug: Acamprosate|Drug: Lithium | Hannover Medical School | Phase 3 | 2015-01-01 | 2017-02-23 |
NCT01305707 | Depression | Device: C-ECT|Drug: PHARMACOTHERAPY | Hospital Universitari de Bellvitge | Phase 4 | 2009-07-01 | 2015-08-28 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们